Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

ChemPartner Adds Peptide Services and Invests in Peptide Startup

publication date: Jan 7, 2016
ChemPartner, the CRO component of China-US ShangPharma, has added peptide chemistry to its list of CRO services. In addition, ShangPharma has made a seed investment in Circle Pharma, a two-year old novel drug company focused on discovering novel peptide-based therapeutics. Circle will move its operations to ChemPartner's South San Francisco facility and collaborate with ChemPartner, though it will remain a separate entity. The size of ShangPharma's investment in Circle was not disclosed. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital